Table 3.
Assessment of inhaler technique by CNS using the UKIG checklist
| Patient ID | Week 1 |
Week 2 |
Week 3 |
Week 4 |
Week 5 |
Week 6 |
Week 7 |
Week 8 |
Week 9 |
Week 10 |
Week 11 |
Week 12 |
| NEMD1 | E | E | E | PaE | E | PaE | E | E | E | PaE | PaE | PaE |
| NEMD2 | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | NR | NR |
| NEMD11 | E | PaE | E | PaE | E | E | E | E | E | E | E | E |
| NEMD14 | PaE | PaE | P | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE |
| NEMD15 | E | E | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| NEMD16 | E | E | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| NEMD31 | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE | PaE |
| NEMD32 | PaE | PaE | PaE | PaE | PaE | NR | NR | NR | NR | NR | NR | NR |
CNS, clinical nurse specialist; E, effective; NEMD, novel electronic monitoring device; NR, no recording; P, poor; PaE, partially effective; UKIG, UK Inhaler Group.